1. Home
  2. FGEN vs GAME Comparison

FGEN vs GAME Comparison

Compare FGEN & GAME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • GAME
  • Stock Information
  • Founded
  • FGEN 1993
  • GAME 2011
  • Country
  • FGEN United States
  • GAME United States
  • Employees
  • FGEN N/A
  • GAME N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • GAME
  • Sector
  • FGEN Health Care
  • GAME
  • Exchange
  • FGEN Nasdaq
  • GAME Nasdaq
  • Market Cap
  • FGEN 33.5M
  • GAME 27.2M
  • IPO Year
  • FGEN 2014
  • GAME 2009
  • Fundamental
  • Price
  • FGEN $7.26
  • GAME $1.90
  • Analyst Decision
  • FGEN Strong Buy
  • GAME Strong Buy
  • Analyst Count
  • FGEN 1
  • GAME 3
  • Target Price
  • FGEN $250.00
  • GAME $3.67
  • AVG Volume (30 Days)
  • FGEN 74.1K
  • GAME 7.7M
  • Earning Date
  • FGEN 08-05-2025
  • GAME 08-13-2025
  • Dividend Yield
  • FGEN N/A
  • GAME N/A
  • EPS Growth
  • FGEN N/A
  • GAME N/A
  • EPS
  • FGEN N/A
  • GAME N/A
  • Revenue
  • FGEN $6,996,000.00
  • GAME $99,579,536.00
  • Revenue This Year
  • FGEN N/A
  • GAME $6.08
  • Revenue Next Year
  • FGEN N/A
  • GAME $21.94
  • P/E Ratio
  • FGEN N/A
  • GAME N/A
  • Revenue Growth
  • FGEN N/A
  • GAME 77.06
  • 52 Week Low
  • FGEN $4.50
  • GAME $0.50
  • 52 Week High
  • FGEN $38.25
  • GAME $2.87
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 60.54
  • GAME 75.08
  • Support Level
  • FGEN $5.37
  • GAME $0.73
  • Resistance Level
  • FGEN $5.73
  • GAME $2.87
  • Average True Range (ATR)
  • FGEN 0.49
  • GAME 0.22
  • MACD
  • FGEN 0.27
  • GAME 0.13
  • Stochastic Oscillator
  • FGEN 83.80
  • GAME 53.88

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.

About GAME GameSquare Holdings Inc.

GameSquare Holdings Inc is engaged to revolutionize the way brands and game publishers connect with hard-to-reach Gen Z, Gen Alpha, and Millennial audiences. Its next generation media, entertainment, and technology help creators and maximize its brand partners return on investment. Its purpose-built platform, provide marketing and creative services, offer data and analytics solutions, and amplify awareness through FaZe Clan.

Share on Social Networks: